Summary & Overview
HCPCS E2100: Blood Glucose Monitor with Integrated Voice Synthesizer
HCPCS Level II code E2100 denotes a blood glucose monitor with an integrated voice synthesizer, a durable medical device that provides audible glucose readings for patients with visual impairment or literacy challenges. Nationally, this device supports diabetes self-management and accessibility, reducing barriers to routine glucose monitoring for vulnerable populations. The code matters for coverage determinations, durable medical equipment policy, and access to audiable-monitoring technologies.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of payer coverage considerations, common billing modifiers, and the clinical context for use in home and outpatient settings. The publication outlines what to expect in benefit design for assistive glucose monitors, typical sites of service, and operational billing elements for DME suppliers.
The report provides benchmarks and policy context where available, highlights common payer approaches to device coverage and documentation, and explains practical billing considerations tied to E2100. Data not available in the input is noted where specific utilization, reimbursement rates, or associated taxonomies and ICD-10 pairings would normally be detailed.
Billing Code Overview
HCPCS Level II code E2100 represents a blood glucose monitor with integrated voice synthesizer, a device designed to measure blood glucose levels and provide audible results for users with visual impairments or other needs for voice output. The service type is durable medical equipment (DME) — assistive monitoring device, intended to support self-monitoring of blood glucose in outpatient and home settings. The typical site of service is home use or other non-facility outpatient settings where patients perform routine glucose monitoring.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with insulin-treated diabetes mellitus who has low vision or blindness and requires an audible glucose reading. The device described by E2100 is a blood glucose monitor with an integrated voice synthesizer supplied to patients who need assistive technology to perform capillary blood glucose testing independently. A usual workflow: a clinician (endocrinologist, primary care physician, or diabetes educator) documents the medical necessity for an accessible monitor during an office visit; durable medical equipment staff or supplier processes the order and verifies patient eligibility with the payer; the device is dispensed to the patient with hands-on education from a diabetes educator or certified diabetes care and education specialist on device operation, safety, and troubleshooting; follow-up visits or phone calls assess device use, glycemic readings, and any need for replacement or additional supplies. Typical sites of service include outpatient clinics, physician offices, durable medical equipment supplier locations, and the patient’s home for delivery and training. Patient scenarios commonly involve vision impairment, documented functional need for audible output, difficulty with manual dexterity that impairs reading standard displays, or cognitive/neurological conditions that require assistive feedback for safe insulin dosing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier applicable (placeholder) |